May 2 (Reuters) - Tourmaline Bio Inc TRML.O:
TOURMALINE BIO REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS
TOURMALINE BIO INC - HAS $275.3 MILLION CASH RUNWAY INTO H2 2027
TOURMALINE BIO INC: QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.89
Source text: ID:nGNX1qqpD5
Further company coverage: TRML.O
((Reuters.Briefs@thomsonreuters.com;))